Many of the company’s main financial headlines were previously reported when Aurora announced its new CEO, and warned a write-down in the neighbourhood of $1.8 billion could lay ahead. However, investors will be likely keeping a close eye on how the company’s net cannabis sales are doing, as well as any further information on its U.S. plans.
Canaccord Genuity analyst Matt Bottomley reduced his price target on Aurora to $10 from $21, reporting that flat-to-declining revenues could be more of an industry-wide trend for Canadian operators, not just Aurora.
New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.
For more of the latest info on Cannabis, check out the Cannabis Trending News hub on Stockhouse.